Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Putin and Modi discuss trade, peace in New Delhi summit
US to widen travel ban to more than 30 countries, Noem says
Putin visits Delhi as Russia, India seek to increase and diversify trade
Hong Kong races to remove scaffolding nets blamed for fuelling deadly fire
Sri Lanka cyclone survivors afraid to go home, stuck in relief centres
